SCHEMBL1144752

SCHEMBL1144752

Cc1ccc2c(C)c(C(=O)O)[nH]c2c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HPGD P15428 1/20 0.54
HTT P42858 1/20 0.54
GFER P55789 1/20 0.54
HSD17B10 Q99714 1/20 0.54
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
NPY1R P25929 1/20 0.50
NPY2R P49146 1/20 0.50
KIF11 P52732 2/20 0.49
MPL P40238 1/20 0.48
MITF O75030 1/20 0.47
MAPT P10636 1/20 0.47
PIN1 Q13526 1/20 0.47
EGFR P00533 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2816058 0.85 ALDH1A1 (0.67) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL11995204 0.84 EIF4A3 (0.66) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL31025922 0.84 ALDH1A1 (0.54) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL31025889 0.82 EGFR (0.59) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL31025912 0.82 MEN1 (0.48) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL1144990 0.82 GPR17 (0.60) MEN1KMT2AKDM4EHPGD
SCHEMBL31025877 0.82 PIN1 (0.49) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL31025893 0.80 KIF11 (0.58) MEN1ALDH1A1KMT2AHPGDHTT
SCHEMBL1144751 0.80 GPR17 (0.64) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL27469947 0.80 MEN1 (0.60) MEN1ALDH1A1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4660193-A1 INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF Korea Research Institute of Chemical Technology (KR) 2025-12-10 EP disclosed
WO-2024162746-A1 INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF 한국화학연구원 2024-08-08 WO disclosed
EP-2297163-B1 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER (US) 2015-07-08 EP disclosed
US-8318762-B2 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2012-11-27 US disclosed
EP-2297163-A1 PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS Pfizer Inc. (US) 2011-03-23 EP disclosed
US-20110028390-A1 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors PFIZER, INC. (US) 2011-02-03 US disclosed
WO-2009144554-A1 PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS PFIZER, INC. (US) 2009-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028390-A1 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB MEN1 3715/4885ALDH1A1 164/4885KMT2A 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.